GLP-1 / GIP dual agonist

Mounjaro

Tirzepatide · Weekly subcutaneous injection

Dual GLP-1/GIP agonist, approved for type 2 diabetes and used off-label for significant weight loss.

Pricing

2.5 mg / per 1 pen$350.60

5 mg / per 1 pen$364.04

7.5 mg / per 1 pen$413.55

10 mg / per 1 pen$413.55

12.5 mg / per 1 pen$501.88

15 mg / per 1 pen$501.88

Start Evaluation

How it works

Activates both GLP-1 and GIP receptors, producing strong appetite suppression and improved insulin response.

Who it's for

Higher weight-loss potential
Patients with type 2 diabetes

Common side effects

NauseaDiarrheaDecreased appetiteConstipation

This is not a complete list. Your clinician will review your full medical history and discuss risks, contraindications, and monitoring before prescribing.

Other options

GLP-1 receptor agonist

Ozempic

Semaglutide

$149–$298 CAD

GLP-1 receptor agonist

Wegovy

Semaglutide

$374.82–$374.82 CAD

GLP-1 / GIP dual agonist

Zepbound

Tirzepatide

$350.6–$501.88 CAD

Not sure which is right for you?

Start your evaluation and a clinician at The Matrix Health will recommend a personalized plan.

Start Evaluation